AstraZeneca-Funded Non-Clinical PhD Studentship: Deciphering cellular determinants of sensitivity to high-LET radiation to inform combination strategies with next-generation Targeted Alpha Therapies
7 days ago
Cambridge
Targeted Alpha Therapy (TAT) selectively delivers high Linear Energy Transfer (LET) alpha-particles to cancer cells, maximising efficacy while minimising toxicity. However, determinants of sensitivity to high-LET radiation, such as alpha particles emitted by TAT, remain largely unexplored. Emerging